Evaluation of malignancy using Ki-67 labeling index for gastric stromal tumor

Gastric Cancer

Volumn 6, Issue 3, 2003, Pages 168-172

  Nagasako, Yoshihide ^a   Misawa, Kazuhito ^a   Kohashi, Shigechika ^a   Hasegawa, Kimiharu ^a   Okawa, Yumi ^a   Sano, Hidekazu ^a   Takada, Akio ^a   Sato, Hidetoshi ^a  

^a SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

Gastric stromal tumor; Ki 67 labeling index

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER RECURRENCE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; MALE; METASTASIS; MITOSIS INDEX; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; STOMACH TUMOR; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MESENCHYMOMA; MIDDLE AGED; MITOTIC INDEX; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; REOPERATION; STOMACH NEOPLASMS; STROMAL CELLS;

EID: 0141867773     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-003-0246-3     Document Type: Article

References (11)

1. Hasegawa T, Yamamoto S, Nojima T, Hirose T, Nikaido T, Yamashiro K, et al. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol 2002;33:111-5.
2. Rosai J. Stromal tumors. In: Rosal J, editor(s) Ackerman's surgical pathology. 8th Ed. St. Louis: Mosby-Year Book; 1996. pp. 645-7; pp. 691-3.
3. Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ, Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome. Am J Clin Pathol 1993;100:428-32.
4. Shimoda T, Fujimoto Y, Hasegawa T, Nakanishi K. A concept and issue of GIST (gastrointestinal stromal tumor). Pathol Clin Med 2002;20:134-40.
5. Wang X, Mori I, Tang W, Utunomiya H, Nakamura M, Nakamura Y, et al. Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST). Jpn J Clin Oncol 2002;9:347-51.
6. Yuasa N, Takagi K, Oota H, Nishi M, Yanagisawa A. Clinicopathological examination of 76 cases of gastric leiomyoma. J Jpn Surg Soc 1992;93:248-56.
7. Sasako M, Katai H, Sano T, Noda N, Maruyama K, Ochiai A, et al. Selection of treatment for leiomyoma of the stomach. Stomach and Intestine 1995;30:1169-74.
8. Nashimoto A, Yabuzaki Y, Tanaka O, Oota T. Diagnosis and treatment for stromal tumor of the stomach - malignant GIST. Geka (Surgery) 2001;63:1051-7.
9. DeMatteo RP, Lewis JJ, Leung D, Muden SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-8.
10. Emocy TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Am J Surg Pathol 1999;23:82-7.
11. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuverson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastric intestinal tumor. N Engl J Med 2001;344:1052-56.